AT402715T - HCV vaccine compositions - Google Patents

HCV vaccine compositions

Info

Publication number
AT402715T
AT402715T AT00975681T AT00975681T AT402715T AT 402715 T AT402715 T AT 402715T AT 00975681 T AT00975681 T AT 00975681T AT 00975681 T AT00975681 T AT 00975681T AT 402715 T AT402715 T AT 402715T
Authority
AT
Austria
Prior art keywords
vaccine compositions
hcv vaccine
hcv
compositions
Prior art date
Application number
AT00975681T
Other languages
German (de)
Inventor
Debbie Drane
John Cox
Michael Houghton
Xavier Paliard
Original Assignee
Csl Ltd
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US16665299P priority Critical
Priority to US22436200P priority
Application filed by Csl Ltd, Novartis Vaccines & Diagnostic filed Critical Csl Ltd
Publication of AT402715T publication Critical patent/AT402715T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AT00975681T 1999-11-19 2000-11-17 HCV vaccine compositions AT402715T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16665299P true 1999-11-19 1999-11-19
US22436200P true 2000-08-11 2000-08-11

Publications (1)

Publication Number Publication Date
AT402715T true AT402715T (en) 2008-08-15

Family

ID=26862451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00975681T AT402715T (en) 1999-11-19 2000-11-17 HCV vaccine compositions

Country Status (12)

Country Link
US (2) US20040191270A1 (en)
EP (1) EP1239876B1 (en)
JP (1) JP2003514872A (en)
KR (1) KR100875483B1 (en)
AT (1) AT402715T (en)
AU (1) AU772617B2 (en)
CA (1) CA2391843C (en)
DE (1) DE60039715D1 (en)
ES (1) ES2311478T3 (en)
HK (1) HK1047892A1 (en)
NZ (2) NZ518999A (en)
WO (1) WO2001037869A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
DE60044236D1 (en) 1999-02-17 2010-06-02 Csl Ltd Immunogenic complex and methods with respect to these
EP1232267B1 (en) * 1999-10-27 2013-03-20 Novartis Vaccines and Diagnostics, Inc. Activation of hcv-specific t cells
PL367526A1 (en) * 2001-06-29 2005-02-21 Chiron Corporation Hcv e1e2 vaccine compositions
EP1467755A1 (en) * 2001-12-21 2004-10-20 Antigenics Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
DK1471936T3 (en) * 2002-01-14 2010-04-26 Novartis Vaccines & Diagnostic HIV vaccine and method of use
CA2511512C (en) * 2002-12-27 2013-10-29 Chiron Corporation Immunogenic compositions containing phospholipid
EP1613647A2 (en) * 2003-04-11 2006-01-11 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Use of hcv proteins
US20070190072A1 (en) * 2004-09-30 2007-08-16 Csl Limited Ludwig Institute For Cancer Research In vivo efficacy of ny-eso-1 plus adjuvant
KR100958505B1 (en) * 2004-07-18 2010-05-17 씨에스엘 리미티드 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
CU23496A1 (en) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech vaccine composition against Hepatitis C virus
AU2005295317B2 (en) * 2004-10-18 2011-10-13 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
EP2357184B1 (en) 2006-03-23 2015-02-25 Novartis AG Imidazoquinoxaline compounds as immunomodulators
DK2200638T3 (en) * 2007-10-09 2016-06-06 Univ Melbourne Compositions for the transfection of cells
NZ583377A (en) * 2007-10-12 2013-11-29 Csl Ltd Method of eliciting an immune response against pandemic influenza virus
US8728489B2 (en) 2008-09-19 2014-05-20 Globeimmune, Inc. Immunotherapy for chronic hepatitis C virus infection
JP2012523379A (en) * 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン Immunogenic compositions and the use thereof
SG184804A1 (en) 2010-04-30 2012-11-29 Temasek Life Sciences Lab Ltd Universal vaccine against h5n1 lineages
AU2011305061B2 (en) 2010-09-22 2016-04-14 Ena Therapeutics Pty Ltd Novel immunostimulatory method
KR20140036127A (en) * 2010-11-26 2014-03-25 더 맥파레인 버넷 인스티튜트 포 메디칼 리서치 앤드 퍼블릭 헬스 리미티드 Compositions and methods
CU24112B1 (en) * 2012-11-05 2015-08-27 Ct De Ingeniería Genética Y Biotecnología Chimeric vaccine antigen against Hepatitis C virus
JP5931113B2 (en) * 2014-04-08 2016-06-08 ザ ユニバーシティー オブ メルボルン Immunogenic compositions and the use thereof

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (en) * 1982-10-18 1982-10-18 Bror Morein Immunogenic membrane protein complex, seen for the front up and tell priority over derav as immune stimulant and as vaccine
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
WO1990001947A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
US5178860A (en) * 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
NZ241954A (en) * 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
US5650398A (en) * 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
DE69434116T2 (en) * 1993-05-05 2005-10-27 Common Services Agency Hepatitis c virus type 4,5 and 6
WO1994026306A1 (en) * 1993-05-12 1994-11-24 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US20030050263A1 (en) * 1994-07-15 2003-03-13 The University Of Iowa Research Foundation Methods and products for treating HIV infection
US6239116B1 (en) * 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
PT721505E (en) * 1994-07-29 2002-10-31 Innogenetics Nv hepatitis virus envelope proteins and purified for use in diagnosis and therapy
AUPM873294A0 (en) * 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
AU686891B2 (en) * 1994-10-12 1998-02-12 Iscotec A.B. Saponin preparations and use thereof in iscoms
GB9513261D0 (en) * 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
SE9600648D0 (en) * 1996-02-21 1996-02-21 Bror Morein Receptorbimdande unit
GB9620795D0 (en) * 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
US6231859B1 (en) * 1996-12-02 2001-05-15 Aquila Biopharmaceuticals, Inc. Saponin adjuvant compositions
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
CA2290646C (en) * 1997-05-20 2008-03-11 Galenica Pharmaceuticals, Inc. Triterpene saponin analogs having adjuvant and immunostimulatory activity
CA2301575C (en) * 1997-05-20 2003-12-23 Heather L. Davis Vectors and methods for immunization or therapeutic protocols
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
CA2302554C (en) * 1997-09-05 2007-04-10 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
US20050031638A1 (en) * 1997-12-24 2005-02-10 Smithkline Beecham Biologicals S.A. Vaccine
WO1999061056A2 (en) * 1998-05-22 1999-12-02 Loeb Health Research Institute At The Ottawa Hospital Methods and products for inducing mucosal immunity
US20040247662A1 (en) * 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
GB9817052D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Biolog Vaccine
EP1104306B1 (en) * 1998-08-10 2006-01-11 Antigenics Inc. Compositions of cpg and saponin adjuvants and methods of use thereof
FR2783170B1 (en) * 1998-09-11 2004-07-16 Pasteur Merieux Serums Vacc Emulsion immunostimulant
DE60044236D1 (en) * 1999-02-17 2010-06-02 Csl Ltd Immunogenic complex and methods with respect to these
US6558670B1 (en) * 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
EP1232267B1 (en) * 1999-10-27 2013-03-20 Novartis Vaccines and Diagnostics, Inc. Activation of hcv-specific t cells
US6986892B1 (en) * 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
FR2814958B1 (en) * 2000-10-06 2003-03-07 Aventis Pasteur vaccine Composition
US7713942B2 (en) * 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
JP2005519990A (en) * 2001-10-12 2005-07-07 コーリー ファーマシューティカル グループ,インコーポレイテッド Methods and products for enhancing the immune response using the imidazoquinoline compound
EP1467755A1 (en) * 2001-12-21 2004-10-20 Antigenics Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
NZ573064A (en) * 2002-04-04 2011-02-25 Coley Pharm Gmbh Immunostimulatory G,U-containing oligoribonucleotides
US7196892B2 (en) * 2002-04-10 2007-03-27 Caelin Gabriel Method and apparatus for isolating RFI, EMI, and noise transients in power supply circuits
AT544466T (en) * 2002-10-29 2012-02-15 Coley Pharm Group Inc Use of CpG oligonucleotides for treatment of hepatitis C virus infection
AU2004253479B9 (en) * 2003-06-17 2011-10-06 Mannkind Corporation Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes
EA200600069A1 (en) * 2003-06-20 2006-08-25 Коли Фармасьютикал Гмбх Small molecule antagonists of toll-like receptors (tlr)
US20050013812A1 (en) * 2003-07-14 2005-01-20 Dow Steven W. Vaccines using pattern recognition receptor-ligand:lipid complexes
EP1663316A2 (en) * 2003-09-25 2006-06-07 Coley Pharmaceutical Group, Inc. Nucleic acid lipophilic conjugates
US20070190072A1 (en) * 2004-09-30 2007-08-16 Csl Limited Ludwig Institute For Cancer Research In vivo efficacy of ny-eso-1 plus adjuvant
US20050215501A1 (en) * 2003-10-24 2005-09-29 Coley Pharmaceutical Group, Inc. Methods and products for enhancing epitope spreading
KR100958505B1 (en) * 2004-07-18 2010-05-17 씨에스엘 리미티드 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
AU2005333126A1 (en) * 2004-07-18 2006-12-21 Csl Limited Methods and compositions for inducing innate immune responses
EP1874325A2 (en) * 2005-04-08 2008-01-09 Coley Pharmaceutical Group, Inc. Methods for treating infectious disease exacerbated asthma
AU2007291887B2 (en) * 2006-09-01 2012-09-27 Csl Limited Method of eliciting or inducing an immune response

Also Published As

Publication number Publication date
WO2001037869A1 (en) 2001-05-31
KR100875483B1 (en) 2008-12-22
EP1239876B1 (en) 2008-07-30
EP1239876A1 (en) 2002-09-18
WO2001037869A9 (en) 2002-07-18
CA2391843A1 (en) 2001-05-31
US20100047271A1 (en) 2010-02-25
NZ518999A (en) 2002-12-20
AU1373001A (en) 2001-06-04
EP1239876A4 (en) 2003-05-02
ES2311478T3 (en) 2009-02-16
HK1047892A1 (en) 2009-01-09
DE60039715D1 (en) 2008-09-11
KR20020073338A (en) 2002-09-23
AU772617B2 (en) 2004-05-06
NZ520976A (en) 2005-01-28
CA2391843C (en) 2011-10-18
US20040191270A1 (en) 2004-09-30
JP2003514872A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
DE60132138D1 (en) Fan
DE60140246D1 (en) warming composition
AT324984T (en) Düsenabdeckeinrichtung
AT322870T (en) Photoablationssystem
AT285207T (en) Facettenarthroplastiegeräte
AT299728T (en) Dosierungsbegrenzer
AT258417T (en) Microcapsules - i
AT262883T (en) Flüssigkeitstransferset
AT271400T (en) inhalateur
AT304344T (en) Microcapsules - iii
AT264863T (en) 28-epirapaloge
AT281757T (en) Axialflussmähdrescher
AT244898T (en) Tropfenzentrierungsverfahren
AT261288T (en) Zerflüssigungshandstück
AT285269T (en) Brachytherapiepatrone
AT287661T (en) Augenanalytfühler
AT258777T (en) Microcapsules - ii
AT289118T (en) Flachantenne
AT295935T (en) Meerwellenenergieumwandler
AT299001T (en) Bifurkationsstenteinführsystem
AT257261T (en) Sms-e-commerce
DE60127608D1 (en) Dental wegwerfauftragevorrichtung
AT279153T (en) Knochenresektionsgerät
AT261289T (en) Zerflüssigungshandstück
DE50110344D1 (en) Ir-absorbing compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties